# The Effect of Plasma Osmolality on Brain Glutamate

> **NCT00611741** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 30 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** furosemide, Na supplements

## Key facts

- **NCT ID:** NCT00611741
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2011-03
- **Final completion:** 2012-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00611741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00611741, "The Effect of Plasma Osmolality on Brain Glutamate". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00611741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*